about
Leukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemiaCD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemiaRight on target: eradicating leukemic stem cells.In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid LeukemiaDepletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.Analogue peptides for the immunotherapy of human acute myeloid leukemia.Enhancement of specific cellular immune response induced by DNA vaccines encoding PML-RARalpha and hIL-2 genes.Anti-tumor immunity in a model of acute myeloid leukemia.
P2860
Q33491557-95F82809-1D67-44C4-B347-FC276A1BDEF5Q34977414-EE431EC3-F089-437F-8E51-1CDDA1E25E1EQ35132225-38F62A21-292F-4366-92B9-77004F5B5EA7Q35681332-532D5A63-20A0-499F-8B29-B660876F583CQ37412327-B6DED594-C3C1-4125-BCEC-20B8E7E35ECEQ38599586-8098AE71-82A4-4D4E-BF8A-9FAE542BC517Q39710209-B3A45771-1461-467A-8D20-9E85C072EEE4Q39886835-D3034865-CFB9-41E9-8F99-D7E11F02BA53
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immunotherapy of myeloid leukaemia.
@ast
Immunotherapy of myeloid leukaemia.
@en
type
label
Immunotherapy of myeloid leukaemia.
@ast
Immunotherapy of myeloid leukaemia.
@en
prefLabel
Immunotherapy of myeloid leukaemia.
@ast
Immunotherapy of myeloid leukaemia.
@en
P2860
P1476
Immunotherapy of myeloid leukaemia
@en
P2093
Azim Mohamedali
N Shaun B Thomas
P2860
P2888
P304
P356
10.1007/S00262-006-0267-Y
P577
2006-12-20T00:00:00Z